Company intelligence / Profile preview

Walden Group

Ownership: Private
Employees: ~6000
Development stage: Commercial

Overview

Walden Group is Europe’s leading independent provider of end-to-end pharmaceutical and healthcare supply chain solutions, offering services from first-mile to last-mile delivery, warehousing, value-added services like secondary packaging and serialization, with full GDP compliance and temperature-controlled transport. The group operates through specialized subsidiaries such as Movianto, Eurotranspharma, Transpharma International, Ciblex, Pharma Pilot.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Eurotranspharma Deutschland GmbH joint venture with four German healthcare carriers for temperature-controlled pharma distribution in Germany

Beyond the preview

Go deeper on Walden Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Walden Group.

Explore the full profile